Published in Int J Urol on April 19, 2012
Tolvaptan in patients with autosomal dominant polycystic kidney disease. N Engl J Med (2012) 9.88
Clinical benefit of statin pretreatment in patients undergoing percutaneous coronary intervention: a collaborative patient-level meta-analysis of 13 randomized studies. Circulation (2011) 2.34
Tolvaptan in autosomal dominant polycystic kidney disease: three years' experience. Clin J Am Soc Nephrol (2011) 1.63
Feasibility of transcatheter intervention for severe aortic stenosis in patients >or=90 years of age: aortic valvuloplasty revisited. Catheter Cardiovasc Interv (2007) 1.51
Pioglitazone improves the phenotype and molecular defects of a targeted Pkd1 mutant. Hum Mol Genet (2002) 1.43
Rationale and design of the TEMPO (Tolvaptan Efficacy and Safety in Management of Autosomal Dominant Polycystic Kidney Disease and its Outcomes) 3-4 Study. Am J Kidney Dis (2011) 1.39
Multidetector CT coronary angiography for patient triage to invasive coronary angiography: Performance and cost in ambulatory patients with equivocal or suspected inaccurate noninvasive stress tests. Catheter Cardiovasc Interv (2009) 1.38
Presence and severity of Chlamydia pneumoniae and Cytomegalovirus infection in coronary plaques are associated with acute coronary syndromes. Int Heart J (2006) 1.26
Prognostic significance of circulating tumor cells in patients with hormone refractory prostate cancer. J Urol (2009) 1.15
Two von Recklinghausen's disease cases with pheochromocytomas and gastrointestinal stromal tumors (GIST) in combination. Int J Urol (2007) 1.08
Supine versus prone position during percutaneous nephrolithotomy: a report from the clinical research office of the endourological society percutaneous nephrolithotomy global study. J Endourol (2011) 1.07
Amino acid transporter LAT3 is required for podocyte development and function. J Am Soc Nephrol (2009) 1.06
Disease-causing missense mutations in NPHS2 gene alter normal nephrin trafficking to the plasma membrane. Kidney Int (2004) 1.04
Clinical utility of coronary CT angiography: coronary stenosis detection and prognosis in ambulatory patients. Catheter Cardiovasc Interv (2007) 1.01
Immunomagnetic quantification of circulating tumor cells in patients with urothelial cancer. Int J Urol (2010) 0.97
Laparoscopic management of urachal remnants in adulthood. Int J Urol (2006) 0.96
Role of amino acid transporter LAT2 in the activation of mTORC1 pathway and the pathogenesis of crescentic glomerulonephritis. Lab Invest (2011) 0.94
Calcium channel blocker versus angiotensin II receptor blocker in autosomal dominant polycystic kidney disease. Nephron Clin Pract (2005) 0.94
Prostatic cyst arising around the bladder neck-cause of bladder outlet obstruction: two case reports. Hinyokika Kiyo (2007) 0.92
A suspected case of paradoxical renal embolism through the patent foramen ovale. Clin Exp Nephrol (2010) 0.92
[Comparison of clinical results between TUR-P and holmium laser enucleation of the prostate (HoLEP) based on the initial experience]. Nihon Hinyokika Gakkai Zasshi (2008) 0.91
Pretreatment serum level of HER2/nue as a prognostic factor in metastatic prostate cancer patients about to undergo endocrine therapy. Int J Urol (2006) 0.91
Local interferon-alpha gene therapy elicits systemic immunity in a syngeneic pancreatic cancer model in hamster. Cancer Sci (2007) 0.89
Renal disease progression in autosomal dominant polycystic kidney disease. Clin Exp Nephrol (2012) 0.88
New genetic causes of pheochromocytoma: current concepts and the clinical relevance. Keio J Med (2005) 0.88
Serum level of macrophage colony-stimulating factor is increased in prostate cancer patients with bone metastasis. Hum Cell (2008) 0.88
Kidney volume and function in autosomal dominant polycystic kidney disease. Clin Exp Nephrol (2013) 0.87
Association of circulating tumor cells with tumor-related methylated DNA in patients with hormone-refractory prostate cancer. Int J Urol (2010) 0.87
The effect of eicosapentaenoic acid on renal function and volume in patients with ADPKD. Nephrol Dial Transplant (2008) 0.86
A histone deacetylase inhibitor enhances adenoviral infection of renal cancer cells. J Urol (2007) 0.86
Alternative antiandrogen therapy in patients with castration-resistant prostate cancer: a single-center experience. Int J Urol (2010) 0.85
Detection of circulating MUC7-positive cells by reverse transcription-polymerase chain reaction in bladder cancer patients. Int J Urol (2004) 0.84
Long-term outcome of phase I/II clinical trial of Ad-OC-TK/VAL gene therapy for hormone-refractory metastatic prostate cancer. Hum Gene Ther (2007) 0.84
Administration route-dependent induction of antitumor immunity by interferon-alpha gene transfer. Cancer Sci (2010) 0.83
Impact of wound blush as an angiographic end point of endovascular therapy for patients with critical limb ischemia. J Vasc Surg (2011) 0.83
Incidence and predictors of the late catch-up phenomenon after drug-eluting stent implantation. Int J Cardiol (2013) 0.82
Value of reverse transcription polymerase chain assay in peripheral blood of patients with urothelial cancer. J Urol (2004) 0.81
Oncological outcome of retroperitoneoscopic nephroureterectomy for upper urinary tract transitional cell carcinoma. Int J Urol (2006) 0.80
Fate of unprotected side branches as related to embolic complications during stent implantation for acute coronary syndromes using a distal protection procedure. Am J Cardiol (2005) 0.80
Evaluation of 2,590 urological laparoscopic surgeries undertaken by urological surgeons accredited by an endoscopic surgical skill qualification system in urological laparoscopy in Japan. Surg Endosc (2011) 0.80
Higher body mass index at the time of acute myocardial infarction is associated with a favorable long-term prognosis (8-year follow-up). Heart Vessels (2011) 0.80
Comparison of serum HER2/neu with immunohistochemical HER2/neu expression for the prediction of biochemical progression in metastatic prostate cancer. Int J Urol (2009) 0.80
Kidney volume estimations with ellipsoid equations by magnetic resonance imaging in autosomal dominant polycystic kidney disease. Nephron (2015) 0.80
Predictors of septic shock in obstructive acute pyelonephritis. World J Urol (2013) 0.79
Allogeneic MHC gene transfer enhances an effective antitumor immunity in the early period of autologous hematopoietic stem cell transplantation. Clin Cancer Res (2007) 0.79
Chlamydia pneumoniae immunoreactivity in coronary artery plaques of patients with acute coronary syndromes and its relation with serology. Am Heart J (2005) 0.79
Expression of galectin-1, a new component of slit diaphragm, is altered in minimal change nephrotic syndrome. Lab Invest (2008) 0.79
Genotypes of autosomal dominant polycystic kidney disease in Japanese. J Hum Genet (2002) 0.79
Safety study of somatostatin analogue octreotide for autosomal dominant polycystic kidney disease in Japan. Clin Exp Nephrol (2014) 0.78
Serum level and immunohistochemical expression of vascular endothelial growth factor for the prediction of postoperative recurrence in renal cell carcinoma. BMC Res Notes (2014) 0.78
Intratumoral interferon-alpha gene transfer enhances tumor immunity after allogeneic hematopoietic stem cell transplantation. Cancer Immunol Immunother (2008) 0.78
The effect of eicosapentaenoic acid on prostate-specific antigen. In Vivo (2006) 0.77
11beta-hydroxysteroid dehydrogenase type 2 is expressed in the human kidney glomerulus. J Clin Endocrinol Metab (2002) 0.77
Enhanced transgene expression in urothelial cancer gene therapy with histone deacetylase inhibitor. J Urol (2005) 0.76
[Predicting postoperative recurrence of renal cell carcinoma using serum vascular endothelial growth factor]. Nihon Hinyokika Gakkai Zasshi (2013) 0.76
A slightly elevated level of N-terminal pro-brain natriuretic peptide can predict coronary artery disease in a population with normal left ventricular function. Heart Vessels (2010) 0.76
Assessment of cyclic changes in the diameter of the aortic annulus using speckle-tracking trans-esophageal echocardiography. Ultrasound Med Biol (2013) 0.75
A pilot study of quality of life of patients with hormone-refractory prostate cancer after gene therapy. Anticancer Res (2009) 0.75
Combined endovascular and open surgical approach for the management of subclavian artery occlusion due to thoracic outlet syndrome. J Card Surg (2011) 0.75
Predictors of prostate cancer on repeat prostatic biopsy in men with serum total prostate-specific antigen between 4.1 and 10 ng/mL. Int J Urol (2003) 0.75
Hemostatic and fibrinolytic activation is less following cutting balloon angioplasty of the coronary arteries. Jpn Heart J (2004) 0.75
Left atrial thrombus causing pulmonary embolism by passing through an atrial septal defect. Circ J (2002) 0.75
[Prevalence and preference with regard to various surgical treatments for benign prostatic hypertrophy: a survey for the Japanese endourology and ESWL society member]. Nihon Hinyokika Gakkai Zasshi (2003) 0.75
Endovascular treatment of innominate artery stenosis via the bilateral brachial approach. Cardiovasc Revasc Med (2010) 0.75
Retroperitoneal laparoscopic single-site nephroureterectomy: Initial operative experience. Asian J Endosc Surg (2012) 0.75
Stent fracture in the left brachiocephalic vein. Cardiovasc Revasc Med (2007) 0.75
Detection of mucin 7 gene expression in exfoliated cells in urine from patients with bladder tumor. Urology (2003) 0.75
Successful endovascular treatment for simultaneous multiple thromboemboli following myocardial infarction. J Invasive Cardiol (2013) 0.75
Internal jugular thrombophlebitis caused by dermal infection. Intern Med (2011) 0.75
A case of paradoxical embolic ST-segment elevation myocardial infarction triggered by sleep apnea. Intern Med (2012) 0.75
[Survey of factors underlying treatment choice for patients with localized prostate cancer (radical prostatectomy vs extrabeam radiotherapy)]. Nihon Hinyokika Gakkai Zasshi (2006) 0.75
[A case of post-traumatic high flow priapism]. Nihon Hinyokika Gakkai Zasshi (2003) 0.75
Emergency percutaneous balloon aortic valvuloplasty using a triple balloon technique to a patient with severe aortic stenosis. Cardiovasc Interv Ther (2013) 0.75